Cough,
OTC Healthcare > Cough, cold and allergy (hay fever) remedies

Cough, Cold And Allergy (Hay Fever) Remedies in Japan

Japan

Euromonitor International's Cough, Cold And Allergy (Hay Fever) Remedies in Japan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Get immediate access to strategic market analysis when you buy reports online

Tables: 54  |  Publication date: Sep 2007
Cost: 
GBP450.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Antihistamines/allergy remedies (systemic); Child-specific cough; cold and allergy remedies; Combination products - cough; cold and allergy (hay fever) remedies; Cough remedies; Decongestants; Medicated confectionery; Pharyngeal preparations

Table of contents

OTC HEALTHCARE IN JAPAN : MARKET INSIGHT

EXECUTIVE SUMMARY

Ongoing growth due to demographic and lifestyle change

Self-medication brings both opportunity and threat

Changes in tax and sales network

Shift towards nuclear family creates innovative packaging

Acquisiton is key to future growth

Vitamins and dietary supplements to dominate projected sales

KEY TRENDS AND DEVELOPMENTS

Demographic change creates demand for anti-ageing products

Legislation eases regulations on OTC sales

Self-medication to prevent illness needs marketing

Increased merger and acquisition activity in manufacturers and retailers

Increasing number of nuclear families and single-person households exerts a growing influence

MARKET INDICATORS

Table 1 Life Expectancy at Birth 2001-2006

MARKET DATA

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 6 Penetration of Private Label by Sector 2002-2006

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Generics

Consumer expenditure on health goods and medical services

Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006

DEFINITIONS

LOCAL COMPANY PROFILES - JAPAN

EISAI CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 1 Eisai Co Ltd: Key Facts

Summary 2 Eisai Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 3 Eisai Co Ltd: Competitive Position 2006

HISAMITSU PHARMACEUTICAL CO INC - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts

Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2006

LION CORP - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 7 Lion Corp: Key Facts

Summary 8 Lion Corp: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 9 Lion Corp: Competitive Position 2006

MIKI CORP - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 10 Miki Corp: Key Facts

Summary 11 Miki Corp: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 12 Miki Corp: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 13 Miki Corp: Competitive Position 2006

ROHTO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 14 Rohto Pharmaceutical Co Ltd: Key Facts

Summary 15 Rohto Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 16 Rohto Pharmaceutical Co Ltd: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 17 Rohto Pharmaceutical Co Ltd: Competitive Position 2006

SANKYO CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 18 Sankyo Co Ltd: Key Facts

Summary 19 Sankyo Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 20 Sankyo Co Ltd: Competitive Position 2006

SATO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 21 Sato Pharmaceutical Co Ltd: Key Facts

COMPANY BACKGROUND

PRODUCTION

Summary 22 Sato Pharmaceutical Co Ltd: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 23 Sato Pharmaceutical Co Ltd: Competitive Position 2006

SSP CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 24 SSP Co Ltd: Key Facts

Summary 25 SSP Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 26 SSP Co Ltd: Competitive Position 2006

TAISHO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 27 Taisho Pharmaceutical Co Ltd: Key Facts

Summary 28 Taisho Pharmaceutical Co Ltd]: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 29 Taisho Pharmaceutical Co Ltd: Competitive Position 2006

TAKEDA CHEMICAL INDUSTRIES LTD - OTC HEALTHCARE - JAPAN

STRATEGIC DIRECTION

KEY FACTS

Summary 30 Takeda Chemical Industries Ltd: Key Facts

Summary 31 Takeda Chemical Industries Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 32 Takeda Chemical Industries Ltd: Competitive Position 2006

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN JAPAN

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006

Table 14 Sales of Decongestants by Type: Value 2001-2006

Table 15 Sales of Decongestants by Type: % Value Growth 2001-2006

Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006

Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006

Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006

Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006

Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006

Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011

Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2008